← Open Payments lookup

KEVIN ASONGLEFAC: Open Payments

NPI 1770139370 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$434 in 21 payments from 9 companies in 2025. Trend: 2023 $112 · 2024 $310 · 2025 $434

Food & beverage: $434
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.5$134
Ferring Pharmaceuticals Inc.5$94
Endo USA, Inc.3$58
ABBVIE INC.2$45
VERTEX PHARMACEUTICALS INCORPORATED2$31
UROGEN PHARMA, INC.1$21
Novartis Pharmaceuticals Corporation1$17
SUN PHARMACEUTICAL INDUSTRIES INC.1$17
BIOPROTECT MEDICAL, INC.1$15

Products named: GEMTESA, ADSTILADRIN, AVEED, JOURNAVX, LUPRON DEPOT, ORGOVYX, JELMYTO, PLUVICTO.

Industry payments across MD — which companies pay providers there.